Presentation on theme: "Addiction: Its a Brain Disease Beyond a Reasonable Doubt."— Presentation transcript:
Addiction: Its a Brain Disease Beyond a Reasonable Doubt
Presentation Objectives Identify impact of substance abuse & addiction Examine contribution of nature vs. nurture Explain how drugs work Understand how prolonged drug use changes brain circuitry Understand how appropriate treatment can help people recover from drug abuse and addiction.
NEUROTOXICITY AIDS CANCER MENTAL ILLNESS NEUROTOXICITY AIDS CANCER MENTAL ILLNESS Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer Mental illness Health care Productivity Accidents Health care Productivity Accidents Homelessness Crime Violence Homelessness Crime Violence
Estimated Economic Cost to Society from Substance Abuse and Addiction: Illegal drugs: $181 billion/year Alcohol: $185 billion/year Tobacco: $158 billion/year Total: $524 billion/year Surgeon Generals Report, 2004; ONDCP, 2004; Harwood, 2000.
Contributors to the Economic Costs of Substance Abuse and Addiction Health care expenditures –Alcohol and drug abuse services –Medical consequences Productivity (lost earnings) –Premature death –Impaired job performance –Institutionalized population –Incarceration –Criminal victimization Other impacts on society –Crime –Social welfare administration –Vehicular accidents Adapted from Harwood et al., Addiction, 1999.
Between 50% and 80% of Adult Male Arrestees Tested Positive for Illicit Drug Use in 2000 Drug Use Correlates with Crime 2000 Arrestee Drug Abuse Monitoring: Annual Report, April 2003.
More than 50% of violent crimes 60-80% of child abuse and neglect cases 50-70% of theft and property crimes 75% of drug dealing Belenko and Peugh, 1998; National Institute of Justice, 1999. The Perpetrator is Involved in Drug Use in…
However… advances in science have revolutionized our fundamental views of drug abuse and addiction, showing us that: abuse is a preventable behavior addiction is a treatable disease
Your Brain on Drugs Today 1-2 Min3-45-6 6-77-88-9 9-1010-2020-30 YELLOW shows places in brain where cocaine goes (striatum) Front of Brain Back of Brain Fowler et al., Synapse, 1989.
Common Myths About Drug Abuse… Drug abuse equates to drug addiction Alcohol is not a drug Addiction is a moral weakness You have to hit rock bottom to recover You have to want treatment for it to be successful Drug abuse is more common among minorities
What is Addiction? A brain disease expressed as a compulsive behavior The continued abuse of drugs despite negative consequences A chronic, potentially relapsing disorder
Why Do People Take Drugs in The First Place? To feel good To have novel: feelings sensations experiences AND to share them To feel better To lessen: anxiety worries fears depression hopelessness
Why do some people become addicted while others do not? Vulnerability
We Know Theres a Big Genetic Contribution to Drug Abuse and Addiction… Drug Abuse and Addiction… ….Overlapping with Environmental Influences that Help Make Addiction a Complex Disease.
high low High DA receptor Low DA receptor DA Receptors and the Response to Methylphenidate (MP) As a group, subjects with low receptor levels found MP pleasant while those with high levels found MP unpleasant Adapted from Volkow et al., Am. J. Psychiatry, 1999. Dopamine receptor level
Drug Abuse Drug/Alcohol Related Traffic Accidents Delinquency Academic Failure and Dropping Out of School Juvenile Depression Sexually Transmitted Diseases (Including HIV/AIDS) Running Away From Home Unwanted Pregnancies Suicidal Behavior Community Peer Cluster Family Individual
Basolateral Amygdala Prefrontal Cortex Mediodorsal Thalamus Motor Nuclei Ventral Pallidum Nucleus Accumbens Ventral Tegmental Area GABA and Glutamate Role in Motivation Adapted from Kalivas and Nakamura, Curr. Opin. Neurobiol., 1999. Dopamine Glutamate GABA
Circuits Involved In Drug Abuse and Addiction All of these must be considered in developing strategies to effectively treat addiction All of these must be considered in developing strategies to effectively treat addiction
Alcohol vs. Other Drugs We know that alcohol impairs the brain and results in addiction with repeated use in the same way as other drugs
0 100 150 200 250 0123 hr Time After Nicotine % of Basal Release Accumbens Caudate NICOTINE Di Chiara and Imperato, PNAS, 1988 Effects of Drugs on Dopamine Release
prolonged drug use changes the brain in fundamental and long-lasting ways Science has generated much evidence showing that…
DA D2 Receptor Availability Control Addicted Cocaine Alcohol DA Reward Circuits DA Reward Circuits DA Drug Abuser Non-Drug Abuser Heroin Meth Dopamine D2 Receptors are Lower in Addiction DA
Dopamine Transporters in Methamphetamine Abusers Normal Control Methamphetamine Abuser Motor Task Loss of dopamine transporters in the meth abusers may result in slowing of motor reactions. Memory task Loss of dopamine transporters in the meth abusers may result in memory impairment. 78910111213 1.0 1.2 1.4 1.6 1.8 2.0 Time Gait (seconds) 46810121416 1.0 1.2 1.4 1.6 1.8 2.0 Delayed Recall (words remembered) Dopamine Transporter Bmax/Kd Volkow et al., Am. J. Psychiatry, 2001..
Implication: Brain changes resulting from prolonged use of drugs may compromise mental and motor functions
Nature Video Cocaine Video Conditioned Association Conditioned Association 1.5 0.5 1.0 2.0 2.5 CRAVING INDUCTION IN A PET SETTING N = 13 CRAVING 5 4 3 2 1 0 Neutral Cocaine STIMULI Childress et al., Am. J. Psychiatry, 1999
Memories Appear to Be A Critical Part of Addiction Its about people, places and things…
Cocaine Film Cocaine Craving: Population (Cocaine Users, Controls) x Film (cocaine, erotic) Garavan et al., Am. J. Psychiatry, 2000. IFG Ant. Cing. Cingulate Signal Intensity (AU) Controls Cocaine Users
But, drug addiction is a chronic illness with relapse rates similar to those of hypertension, diabetes, and asthma McLellan et al., JAMA, 2000.
Relapse Rates Are Similar for Drug Addiction & Other Chronic Illnesses Drug Addiction Type I Diabetes 0 10 20 30 40 50 60 70 80 90 100 Hypertension Asthma 40 to 60% 30 to 50% 50 to 70% Percent of Patients Who Relapse McLellan et al., JAMA, 2000.
Addiction is Similar to Other Chronic Illnesses Because: Recovery from it--protracted abstinence and restored functioning--is often a long-term process requiring repeated treatments Relapses to drug abuse can occur during or after successful treatment episodes Participation in self-help support programs during and following treatment can be helpful in sustaining long-term recovery Therefore…
Hypertension Tx Stage of Tx YES Addiction Tx Stage of Tx NO There is a right way and a wrong way to Measure the Outcome of Treating Chronic Illnesses like Addiction
Full recovery is a challenge but it is possible …
DAT Recovery with prolonged abstinence from methamphetamine [C-11]d-threo-methylphenidate Volkow et al., J. Neuroscience, 2001. low high Normal Control Methamphetamine Abuser (1 month detoxification) Methamphetamine Abuser (14 month abstinent)
Treatment Reduces Drug Use and Recidivism No treatment CREST Dropouts CREST Completers + Aftercare No treatment CREST Dropouts CREST Completers + Aftercare Delaware Work Release Therapeutic Community (CREST) + Aftercare 3 Years After Release (N=448) p < 0.05, compared to No Treatment group Percentage of Participants Drug-Free Arrest-Free
We Need to Keep Our Eye on the Real Target the Real Target Abstinence Functionality in Family, Work and Community In Treating Addiction…
Since it was established in 1974, NIDA has supported research on drug abuse treatment for individuals who are involved with the criminal justice system.
Surgeon Generals Report, 2004; ONDCP, 2004; Harwood, 2000. Adapted from Harwood et al., Addiction, 1999. 2000 Arrestee Drug Abuse Monitoring: Annual Report, April 2003. Belenko and Peugh, 1998; National Institute of Justice, 1999. Fowler et al., Synapse, 1989. Adapted from Volkow et al., Am. J. Psychiatry, 1999. Adapted from Kalivas and Nakamura, Curr. Opin. Neurobiol., 1999. Di Chiara et al., Neuroscience, 1999. Fiorino and Phillips, J. Neuroscience, 1997. Di Chiara and Imperato, PNAS, 1988 Volkow et al., Am. J. Psychiatry, 2001 Garavan et al., Am. J. Psychiatry, 2000. Childress et al., Am. J. Psychiatry, 1999. Source: Adapted from Volkow et al., Neuropharmacology, 2004. McLellan et al., JAMA, 2000. Volkow et al., J. Neuroscience, 2001.
We want to thank TASC, Inc., of Illinois for their contribution to this presentation.